Perspective Therapeutics (CATX) Net Equity Issued and Repurchased (2011 - 2026)
Perspective Therapeutics' Net Equity Issued and Repurchased was $160,000 in Q2 2026, up 10.3% from $145,000 a year earlier but down 44.8% from the prior quarter.
Powered by 
Analysis
Perspective Therapeutics (CATX) Net Equity Issued and Repurchased (2011 - 2026) Analysis & Trends
On a trailing twelve-month basis, Perspective Therapeutics' Net Equity Issued and Repurchased was $676,000 through Jun 30, 2026, down 40.9% year-over-year; for FY2025, it was $371,000, down 70.4% from FY2024.
- Net Equity Issued and Repurchased shows a five-year compound annual growth rate of 23.1% (FY2020 to FY2025).
- In earlier years, Net Equity Issued and Repurchased was $1.25 million in FY2024 (+126.2%), $554,000 in FY2023, $30,000 in FY2022 and $7.8 million in FY2021.
- Quarterly Net Equity Issued and Repurchased has moved between -$26,000 (Q4 2022) and $642,000 (Q3 2024) over five years.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | -377.00 Mn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | -966.00 Mn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | -5.00 Mn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | -406.00 Mn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 4.00 Mn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | -283.00 Mn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | - |
| 10 | Perspective Therapeutics | 104.44 Mn | -132.46 Mn | - | 160,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 160,000.00 |
| Mar 31, 2026 | 290,000.00 |
| Sep 30, 2025 | 226,000.00 |
| Jun 30, 2025 | 145,000.00 |
| Dec 31, 2024 | -287.70 Mn |
| Sep 30, 2024 | 644,000.00 |
| Jun 30, 2024 | 122.09 Mn |
| Mar 31, 2024 | 166.34 Mn |
| Dec 31, 2023 | 364,000.00 |
| Sep 30, 2023 | 22,000.00 |
| Jun 30, 2023 | 532,000.00 |
| Dec 31, 2022 | -26,000.00 |
| Sep 30, 2022 | 28,000.00 |
| Dec 31, 2021 | 56,000.00 |
| Jun 30, 2021 | -56.12 Mn |
| Mar 31, 2021 | 8.10 Mn |
| Jun 30, 2019 | -7.36 Mn |
| Mar 31, 2019 | -9,000.00 |
| Dec 31, 2018 | -113,000.00 |
| Sep 30, 2018 | 7.49 Mn |
API Access
Perspective Therapeutics Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=CATX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "CATX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=CATX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();